Vedran1 Posted - 4 hours ago

$RNAZ A few personal comments regarding reading 10-Q filed Nov 14 2024 about the the Collaborations with Debiopharm and with "Another biotechnology company" status: Transcode was testing DELIVERY of the respective company's studied MESSENGER RNAs using Transcode's proprietary TTX platform - NOT the same as TTX-MC138 that uses TTX to deliver an ANTISENSE OLIGONUCLEOTIDE (ASO) with anti microRNA-10b properties - as used in the current Transcode's clinical study. Debiopharm and "Another biotechnology company" might have flawed therapeutics candidates to deliver or a flawed study design and/or scientific thesis - not necessarily a problem with the Transcode's TTX delivery method itself. Certainly, it would be nice if those intial attempts and collaborations worked well. It would facilitate and attract new collaborations and other deals.

Vedran1 Posted - 15 hours ago

$RNAZ Tom answered the question about the current status of the project with Akribion Genomics. He noted that the project is still in development and that Akribion is evaluating the results that Transcode sent to them and waiting for their response. He also noted that the results from Transcode's standpoint are considered "pretty good".

Drizzyman Posted - 1 day ago

$RNAZ On September 17, we found out that the first 2 patients were dosed. I would hope that we receive information on month 3 about those patients continuing treatment as well as dose updates. Per the clinical trial website: "Detailed Description The study will consist of 2 phases, dose escalation and dose expansion, with 3 study periods: Screening (up to 28 days), Treatment (28-day treatment cycles, with dosing on Day 1), and Survival Follow-up (every 3 months). Each 28-day cycle is comprised of 1 dose of study drug administered as an intravenous (IV) infusion on Day 1."

Vedran1 Posted - 1 day ago

$RNAZ Can not wait to see insiders decisively buying RNAZ, especially now when the votes went their way.

gscdefense Posted - 1 day ago

$RNAZ low volume but price has still held. somewhat strange after the recounting of the call from numerous shareholders here

septrading Posted - 1 day ago

$RNAZ it all comes down to the efficacy now. If this drug works, the tiny number of shares after the RS and any amount of ATM they do will mean very little to where the stock price will go. I'm holding a chunk of shares equivalent to my swing profits here. Just hoping some news comes before those timelines in the last investor deck.

Hovius Posted - 1 day ago

$RNAZ so basically.. get your money out, wait for it to RS and then dilute back to $0.50 and then, maybe, buy some… Freaking $MULN of pharmaceutical world..

Vedran1 Posted - 2 days ago

$RNAZ I did not like Tom saying (in my own words and recollection) that July offering was OK-ed by various experts in the field, including by Nasdaq, prior to the offering - and then only after the offering Nasdaq was not OK with it. It also sounds the management was rushed into accepting oferring terms to not make them worse, by given a 3-day deadline to execute ATM offering. Tom claims it was all bona fide (in good faith).

Vedran1 Posted - 2 days ago

$RNAZ

gscdefense Posted - 2 days ago

$RNAZ good news since we should all expect a mac 40:1 RS and a preceeding 20-30% drop after. we will have a very small float and able to get some shares at all time low relative to pre split level. one would expect that between now and feb/mar we should know for sure whether the drug/trials are worth a damn or not so hopefully not being strung along wondering what if for too much longer. and IF and a big IF based on the actions and attitude of spectrum boy at the helm, it could go to the moon in a day with such a low float. even if they start offering immediately, shouldnt add much shares

Vedran1 Posted - 2 days ago

$RNAZ My take listening to the meeting: Since all was approved, no delisting likely, more offering and dilution coming - and with reverse split if needed. Tom was justifying the July offering terms without any apology. I felt the meeting was very cold, extremely brief and standoffish. I felt brushed off, to phrase it politely. There was no enthusiasm, no significant words of encouragement toward shareholders. While some questions were addressed as above - many important shareholders questions and concerns remained unanswered. Good news: We are staying listed and I think some of our bitter words came to the management's eyes and ears. Would it change anything by the way management treats its shareholders and what does happen next with the management and Transcode remains to be seen.

Hovius Posted - 2 days ago

$RNAZ Can anyone share meeting notes?

Hovius Posted - 2 days ago

$RNAZ This will likely take a massive dump today.. again..

phantomtrader75 Posted - 2 days ago

$RNAZ they got their way and approved every proposal.

Luna1997 Posted - 2 days ago

$RNAZ 5:30 AM , im up, im ready & steady. The day is here, dont break my heart RNAZ 🗣️🔜✈️

Luna1997 Posted - 2 days ago

$RNAZ faith brother we held this long 🙏🙏

phantomtrader75 Posted - 2 days ago

$RNAZ anyone else a little nervous?

Hass19 Posted - 2 days ago

$RNAZ It’s time again 🚀

phantomtrader75 Posted - 3 days ago

$RNAZ I VOTED NO ACROSS THE BOARD

clamhugger95 Posted - 3 days ago

$RNAZ Here's what's happening. They ran out of money and their options are to sell out/take on a big investor/partner, or do an RS to keep their nasdaq listing so that they can raise money on the backs of retail investors. They want to do the latter so that they can retain as much control of the company as possible, because that's how they will make the most money. Tough shit. I'm not willing to donate to their trust funds just because they don't want to share their profits with a big investor. Vote NO across the board, force them to do what they will need to do eventually anyway: get bought out.

septrading Posted - 3 days ago

$RNAZ twilight zone action...I'm back in to see how it all goes down following the vote.

phantomtrader75 Posted - 3 days ago

$RNAZ buyout rumor leaked…

Luna1997 Posted - 3 days ago

$RNAZ wtf why 😂now?

Itinerant Posted - 3 days ago

$RNAZ I wonder if this rally means something behind it. I hope.

Travelling Posted - 3 days ago

$pulm bought more to hold, watching $pxs $rnaz $coin

Vedran1 Posted - 3 days ago

$RNAZ Here are some of big questions I have regarding protecting the remaing Transcode's shareholders' value: 1. Could Transcode succeed on its own without further TOXIC financing run by the current management? 2. Is Transcode hopeless and has reached the point of no return, regardless of who would be in control at this point? 3. Should Transcode restructure and/or start selling its intelectual properties or the whole company - and so try to maximize any of remaing shareholders'value? 4. Will the current Transcode management continue its toxic march bringing the Transcode closer and closer to BK and a total loss to its shareholders? 5. Could we do anything about the above besides hopelessly and helplessly spectating, like voting out the CEO or the management?

rock_it_stocks Posted - 3 days ago

$RNAZ There are over 100 studies of the role of miR-10b in at least 18 cancer types over the last 15 years, including some with contributions from our co-founders, making it one of the most studied microRNAs. Studies have shown that an inhibition of miR-10b "prevents the onset of metastasis and eliminate existing metastases, even after treatment has been discontinued." Metastases are responsible for about 90% of all cancer deaths, due to a lack of therapeutics. In Phase 0, a microdose of TTX-MC138 reduced miR-10b by 66%, 24 hours after injection. In another study, MN-anti-miR10b decreased miR-10b by 90% in 24-48 hours, and a 99% downregulation was observed within two weeks. It seems as though this data is quick to ascertain. It's been over two months since the first Phase 1 patients were dosed with 0.4mg/kg of TTX-MC138. How can the CEO say there can be no assurance that this data will be released? IMO, something is rotten in the state of Denmark, so I voted against all three proposals.

gscdefense Posted - 3 days ago

$RNAZ 1m shares available @ 18% cost to borrow. thats terrible. friday might be a blood bath.

phantomtrader75 Posted - 4 days ago

$RNAZ Dear Shareholders, At our upcoming Special Meeting to be held November 22, shareholders are being asked to authorize our Board of Directors to effect a reverse split - only if the Board determines that doing so is necessary as described below. Many shareholders rightly ask why this request. Some believe that the potential announcement of additional positive clinical data or other good news will favorably impact our stock price. However, there is no assurance that any good news will occur, will occur by the deadline required, or that the stock will rise after any such positive announcements).

Hovius Posted - 4 days ago

$RNAZ today we regain some of our massive losses..